Dictionary

The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.

451–500 of 666 terms matching “Cost”

H

Health InsuranceMedical Insurance, Health Coverage
Health insurance is a financing arrangement that pools prepaid contributions and covers specified healthcare costs when insured members need care, thereby sharing financial risk across the insured population.
Health Services ResearchHSR, Health Systems Research
In health economics, the multidisciplinary study of how people access health care, what it costs, and its outcomes, to inform policy and practice.
Healthcare PerspectiveHealth System Perspective, Third-Party Payer Perspective
An analytic viewpoint including only costs and outcomes falling on the healthcare payer or provider, excluding broader costs such as productivity loss.
Healthcare Sector PerspectiveHealth Sector Perspective, Health Care Sector Viewpoint
An analytic viewpoint including costs and outcomes across the healthcare system broadly, but still excluding costs falling entirely outside the health sector.
Heart Transplant EconomicsCardiac Transplant Economics, Heart Graft Economics
The application of health economic evaluation to heart transplantation, weighing procedure and lifelong immunosuppression costs against survival benefit for end-stage failure.
Hepatitis C EconomicsHCV Economics, Hep C Economics
The application of health economic evaluation to hepatitis C, evolving substantially as curative antiviral treatment costs have declined and eligible populations expanded.
Hierarchical Condition CategoryHCC, Condition Category Model
A US Medicare Advantage risk classification system grouping diagnosis codes into hierarchical, clinically related categories to predict future healthcare costs.
High Deductible Health PlanHDHP, High-Deductible Plan
A plan with a deductible above a regulatory minimum threshold, giving lower premiums but requiring a larger upfront share of routine costs.
Highly Specialized TechnologyHST, Highly Specialised Technology Pathway
A distinct evaluation pathway for treatments addressing very rare conditions, applying different evidentiary and cost-effectiveness standards than common conditions.
Hospital-Acquired InfectionIn-Hospital Infection, Hospital Infection
An infection a patient develops during care in a healthcare facility, not present or incubating at admission, a largely preventable cost.
Hyperlipidemia EconomicsEconomics of Hyperlipidaemia, High Cholesterol Economics
The application of health economic evaluation to elevated blood lipid levels, assessing lipid-lowering medication cost against long-term cardiovascular benefit.
Hypertension EconomicsEconomics of Hypertension, High Blood Pressure Economics
The application of health economic evaluation to high blood pressure, comparing medication classes and combinations for cost-effectiveness in cutting cardiovascular events.

I

Immunotherapy EconomicsImmuno-Oncology Economics, Economics of Immunotherapy
The application of health economic evaluation to cancer immunotherapy, comparing substantial upfront cost against durable clinical responses observed in some patients.
Impact AssessmentDecision Consequence Review, Consequence Evaluation
An evaluation of the anticipated or actual consequences of an assessment decision, covering patient outcomes, costs, and societal effects.
Incomplete Treatment
A coping strategy in which a patient begins but does not complete a prescribed treatment course due to cost concerns.
Incremental Analysis MethodIncremental Approach, Marginal Comparison Method
An analytic approach comparing the additional cost and effect of one option relative to the next best alternative, rather than each option's total.
Incremental Net BenefitINB, Incremental Net-Benefit Statistic
The difference in expected net benefit between two competing interventions, found by converting the incremental health effect into money and subtracting incremental cost.
Incremental Net Monetary BenefitINMB, Incremental Monetary Net Benefit
Incremental net monetary benefit, or INMB, converts the difference in health outcomes between two alternatives into a monetary value at a stated cost-effectiveness threshold and then subtracts their difference in cost.
Individual Patient SimulationIPS, Patient-Level Simulation, Individual-Level Simulation, Microsimulation, Patient-Level Microsimulation, Individual-Based Simulation, Individual Patient Modelling, Individual Patient Modeling
Individual patient simulation is a modelling approach that generates separate patient histories under specified rules and aggregates their costs and health outcomes for a target population.
Inflation AdjustmentPrice Rebasing, Real-Terms Adjustment
The process of restating cost data from different time periods in constant, comparable price terms, typically using a relevant price index.
Innovation AssessmentInnovation Evaluation
An evaluation of how far a new technology advances on the existing standard of care, informing whether its novelty justifies additional cost.
Institutional PerspectiveHospital Perspective, Provider Institution Perspective
An analytic viewpoint including only costs and outcomes relevant to a single institution, such as a hospital, rather than the broader health system.
International ComparisonCross-Country Comparison, Cross-National Comparison
An analysis examining how health outcomes, costs, or policies differ across multiple countries, identifying best practices and system design effects.
Interoperability SavingsInteroperability Benefits, Data-Exchange Savings
The cost savings and efficiency gains achieved when healthcare information systems can seamlessly exchange data, avoiding duplication and administrative burden.
Intervention PerspectiveIntervention-Level Perspective, Intervention-Defined Viewpoint
An analytic viewpoint defined by the specific intervention being studied, including all costs and outcomes directly attributable to it regardless of who bears them.
Interventional Cardiology EconomicsEconomics of Interventional Cardiology, Cath Lab Economics
The application of health economic evaluation to catheter-based cardiac procedures, comparing cost and outcomes against surgical alternatives and medical management.
Inventory Management HealthMedical Inventory Management, Stock Management
The processes an organisation uses to track and optimise its supply of medical products, balancing availability against excess inventory costs.
Investment HorizonInvestment Time Horizon, Payback Horizon
The length of time over which an investment's costs and returns are expected to be realised and evaluated.

K

Kidney Transplant EconomicsRenal Transplant Economics, Economics of Kidney Transplantation
The application of health economic evaluation to kidney transplantation, weighing procedure and lifelong immunosuppression costs against benefit relative to long-term dialysis.

L

League Table ConstructionICER Ranking, League Table Assembly
The process of assembling and ranking incremental cost-effectiveness ratios from multiple separate studies into a single comparative table to guide resource allocation.
Lifetime MaximumLifetime Limit, Lifetime Benefit Cap
A cap on the total amount an insurance plan will pay toward covered costs over an individual's entire coverage duration.
Limited Societal PerspectiveRestricted Societal Perspective, Modified Societal Perspective
An analytic viewpoint including healthcare sector costs along with a defined subset of non-healthcare costs, such as informal carer time, short of a full societal view.
Linear Model HealthLinear Predictor Model, Health Linear Model
A statistical or decision-analytic model in which inputs and outputs are related by a simple linear function, such as a constant per-unit cost.
Liver Transplant EconomicsHepatic Transplant Economics, Liver Graft Economics
The application of health economic evaluation to liver transplantation, weighing procedure and lifelong immunosuppression costs against survival benefit for end-stage disease.
Local PerspectiveSub-National Perspective, Local Health Authority Perspective
An analytic viewpoint considering costs and outcomes relevant to a specific region or local health authority, rather than a national health system.
Lookup TableReference Table, Precomputed Value Table
A data structure storing precomputed values, such as mortality rates or unit costs, indexed for quick retrieval within a health economic model.
Low-Income SubsidyExtra Help Subsidy, Part D Low-Income Assistance
Financial assistance reducing the cost of health insurance or healthcare specifically for individuals or households with limited resources.
Low-Value CareLow-Value Service, Wasteful Care
Healthcare services providing little or no clinical benefit relative to cost, or carrying harm risk exceeding likely benefit.

M

Mail-Order PharmacyMail-Order Dispensing, Home Delivery Pharmacy
A pharmacy service dispensing and delivering prescription medications directly to patients by mail, typically at lower cost for maintenance medications.
Malpractice RVUMP RVU, Professional Liability RVU
A US Medicare relative value component reflecting the professional liability insurance cost attributable to providing a specific service.
Managed Care OrganizationMCO, Managed Care Insurer
An entity coordinating healthcare delivery for a defined population using a contracted provider network and utilisation management tools to control costs.
Marginal AnalysisAnalysis at the Margin, Incremental Reasoning
An approach to resource allocation examining the additional cost and benefit of small changes in an activity's level, rather than its total cost and benefit.
Market FailureMarket Inefficiency, Allocation Failure, Market Imperfection
A market failure occurs when market exchange does not produce an efficient allocation of resources because prices or incentives fail to reflect relevant costs, benefits, information or competitive conditions.
MCDA in HTAMulti-Criteria HTA, MCDA Appraisal
The application of multi-criteria decision analysis within assessment, weighing multiple factors such as benefit, cost, and equity together explicitly.
Mini-HTAMini Health Technology Assessment, Rapid Hospital HTA
A simplified, abbreviated form of assessment for use at hospital or department level, typically applied to lower-cost or lower-risk technologies.
Minimum Effective DoseMED, Threshold Dose
The lowest drug dose that produces a clinically meaningful therapeutic effect, important for both safety and avoiding unnecessary medication cost.
Minimum ValueMV Standard, Employer Plan Value Test
A US regulatory standard requiring an employer plan cover at least sixty percent of allowed benefit costs to satisfy the employer mandate.
Model AdaptationModel Repurposing, Setting Transfer
The process of modifying an existing model, built for one country, so it validly reflects the practice, costs, and population of another.
Model HorizonModelling Horizon, Projection Period
The total length of time over which a decision-analytic model simulates costs and outcomes, from short-term to full lifetime.
Model OutputModel Results, Analysis Output
The results produced by a health economic model, such as total expected cost, QALYs, and the resulting incremental cost-effectiveness ratio.